CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Smith & Nephew cuts 2026 outlook as US knee implant sales slide","$":{"href":"/medtech/smith-nephew-cuts-2026-outlook-us-knee-implant-sales-slide","hreflang":"en"}}]}

EarningsNegative
AI Analysis

Summary

Smith & Nephew has lowered its 2026 sales outlook due to weakness in U.S. orthopedics and wound care, despite stronger growth in sports medicine.

Financial Highlights

Guidance

lowered 2026 sales outlook

Importance:5/10
Sentiment:
-0.70
orthopedicsknee implantswound caresports medicineguidance reductionUS market weakness
Related Companies

Read the original article

Published by FierceBiotech on August 4, 2026 11:23 AM

Read Original